Trial Profile
Phase II trial of IT 139 in patients with non-pancreatic neuroendocrine tumours
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2013
Price :
$35
*
At a glance
- Drugs BOLD 100 (Primary)
- Indications Neuroendocrine tumours
- Focus Therapeutic Use
- 04 Jul 2013 New trial record